BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 15383578)

  • 1. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
    Urban JA; Winandy S
    J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.
    Penninger JM; Sirard C; Mittrücker HW; Chidgey A; Kozieradzki I; Nghiem M; Hakem A; Kimura T; Timms E; Boyd R; Taniguchi T; Matsuyama T; Mak TW
    Immunity; 1997 Aug; 7(2):243-54. PubMed ID: 9285409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice.
    Urban JA; Brugmann W; Winandy S
    J Immunol; 2009 Apr; 182(7):3955-9. PubMed ID: 19299690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.
    Yin X; Ladi E; Chan SW; Li O; Killeen N; Kappes DJ; Robey EA
    J Immunol; 2007 Dec; 179(11):7358-64. PubMed ID: 18025179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
    Xi H; Kersh GJ
    J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantity of TCR signal determines positive selection and lineage commitment of T cells.
    Watanabe N; Arase H; Onodera M; Ohashi PS; Saito T
    J Immunol; 2000 Dec; 165(11):6252-61. PubMed ID: 11086060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coreceptor signal strength regulates positive selection but does not determine CD4/CD8 lineage choice in a physiologic in vivo model.
    Erman B; Alag AS; Dahle O; van Laethem F; Sarafova SD; Guinter TI; Sharrow SO; Grinberg A; Love PE; Singer A
    J Immunol; 2006 Nov; 177(10):6613-25. PubMed ID: 17082573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells.
    Hayashi K; Natsume W; Watanabe T; Abe N; Iwai N; Okada H; Ito Y; Asano M; Iwakura Y; Habu S; Takahama Y; Satake M
    J Immunol; 2000 Dec; 165(12):6816-24. PubMed ID: 11120804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
    Liu X; Taylor BJ; Sun G; Bosselut R
    J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.
    Volkmann A; Barthlott T; Weiss S; Frank R; Stockinger B
    J Exp Med; 1998 Sep; 188(6):1083-9. PubMed ID: 9743527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired generation of CD8+ thymocytes in Ets-1-deficient mice.
    Clements JL; John SA; Garrett-Sinha LA
    J Immunol; 2006 Jul; 177(2):905-12. PubMed ID: 16818745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of thymic selection by expression of an immediate-early gene, early growth response 1 (Egr-1).
    Miyazaki T; Lemonnier FA
    J Exp Med; 1998 Aug; 188(4):715-23. PubMed ID: 9705953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RasGRP1 transmits prodifferentiation TCR signaling that is crucial for CD4 T cell development.
    Priatel JJ; Chen X; Dhanji S; Abraham N; Teh HS
    J Immunol; 2006 Aug; 177(3):1470-80. PubMed ID: 16849453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.
    Shanker A; Auphan-Anezin N; Chomez P; Giraudo L; Van den Eynde B; Schmitt-Verhulst AM
    J Immunol; 2004 Apr; 172(8):5069-77. PubMed ID: 15067090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.